Loading

ACTIVISM

  • by NORML May 7, 2018

    Dear Friends,

    On Friday, May 4, 2018, the New Approach Missouri medical marijuana initiative campaign filed more than 372,400 signatures with the Office of the Missouri Secretary of State in Jefferson City.  Only 168,000 valid signatures are required in order to place the legalization of medical access to cannabis for therapeutic purposes on the ballot in Missouri in November of 2018.

    Fieldworks, the professional petitioning company retained by NAM did an excellent job of gathering signatures and keeping the campaign’s Board of Directors informed, on a daily basis, of the number of signatures gathered in each county and each congressional district in our state.  We are virtually certain to have well in excess of the required signatures to be certified for the November ballot.

    This accomplishment is the result of the generosity of hundreds of donors and the work of hundreds of volunteers who gathered signatures for this initiative.  I thank all of you who have contributed generously to support this effort.  I ask you to consider making a donation at this time to support the campaign to pass this measure by going to NewApproachMissouri.org.

    All polling has indicated that support for medical marijuana in Missouri is well above 60%.  Only 50% of voters is required in order for this initiative to succeed in amending our state’s Constitution.  Although one or possibly two other medical marijuana initiatives may be placed on the ballot, ours will be first among the Constitutional amendments on this topic.  If both of the two Constitutional amendment initiatives pass, the one with more votes will prevail.

    The other two medical marijuana initiatives being circulated do not allow for any patient cultivation.  The other Constitutional amendment initiative would impose the highest tax on medical marijuana in the country.  That tax would go to support a medical research institute which will be required to be headed by one who is both a lawyer and a doctor.  The individual who filed this initiative happens to hold both a J.D. and an M.D. degree.  Further, that research institute’s board of directors will be hand-picked by the individual who filed the initiative, the same individual who will apparently be heading that research institute, which would be funded by imposing a high tax on medical marijuana patients, who would have no legal alternative to purchasing cannabis from dispensaries through this very restrictive proposal.

    The other initiative proposes to enact a statutory law.  If either of the Constitutional amendments passes, this statutory initiative will be rendered irrelevant.  Further, the Missouri General Assembly has demonstrated that it will not hesitate to repeal or radically amend any statutory initiative passed by the voters.

    Please contact me with any questions or concerns.

    Sincerely,

    Dan Viets, Chair

    New Approach Missouri

    Board of Directors

    For more info, please contact Dan Viets via email at danviets@gmail.com. You can also follow New Approach Missouri on FaceBook and Twitter!

  • by NORML May 1, 2018


    The National Organization for the Reform of Marijuana Laws Political Action Committee (NORML PAC) has announced its endorsement of Beto O’Rourke for Senate in his race to unseat Senator Ted Cruz in Texas.

    “Beto has been a true champion for abolishing our disastrous prohibition on marijuana since the very beginning of his political career as a city council member in El Paso. We were pleased to support him in his previous campaign for the House of Representatives and excited to endorse him again in his race for the US Senate,” said NORML PAC Executive Director Erik Altieri, “As Senator, O’Rourke will be an outspoken and indispensable ally in reforming our federal laws relating to marijuana and fight to finally end our failed prohibitionist policies that are currently tearing apart families, oppressing communities of color, squandering countless tax dollars, and filling the coffers of criminal cartels. The time has come for our nation to move towards the sensible policy of regulation and legalization, sending Beto to the Senate would bring us yet another step closer to that goal.”

    “We must end the federal prohibition on marijuana in this country,” said O’Rourke. “Texas should be leading the way by encouraging comprehensive reforms in drug control policies that have had a devastating effect on communities of color.”

    Recent polling on the Texas Senate race showed O’Rourke running neck and neck with Ted Cruz with Cruz claiming the support of 47% of state voters and 44% supporting O’Rourke.

    According to a 2017 poll by the University of Texas, 83 percent of Texans support legalizing marijuana for some use and 53 percent would go beyond legal medical marijuana to allow possession for any use.

    According to an April 2018 poll from Quinnipiac University, 63% of all Americans support the legalization of marijuana nationwide.

    “Texas ranks as one of the states with the highest arrests rates for simple possession of marijuana, at an estimated cost of 1.5 billion in taxpayer money annually,” said Jax Finkel, Executive Director of Texas NORML. “Beto O’Rourke understands that our federal prohibition is a failed policy and it is past time for Congress to end it and allow states like Texas the freedom to pursue new, sensible alternatives.”

  • by Paul Armentano, NORML Deputy Director April 26, 2018

    Legalize MarijuanaElection officials today confirmed that proponents of a statewide ballot measure, The Michigan Regulation and Taxation of Marihuana Act, have gathered a sufficient number of signatures from registered voters to place it on the electoral ballot this November.

    Proponents of the voter-initiated measure, The Coalition to Regulate Marijuana Like Alcohol, submitted more than 360,000 signatures to qualify it for the November 2018 ballot. The initiative permits those over the age of 21 to grow and possess personal use quantities of cannabis and related concentrates, while also licensing activities related to the commercial marijuana production and retail marijuana sales.

    According to statewide polling commissioned by Michigan NORML, which is a leading member of the Coalition, 61 percent of voters say that they intend to vote yes on the measure.

    Voters in other states will also be deciding on marijuana-related ballot questions later this year. Oklahomans will decide in June on State Question 788, which permits qualified patients to access and cultivate marijuana for therapeutic purposes. Utah voters are also expected to decide on a narrower medicalization measure in November, though officials have yet to officially certify that measure for the ballot. Proponents of a medical marijuana measure in Missouri have surpassed the number of signatures required to place it on the November ballot, well ahead of the state’s May 6 deadline. In South Dakota, officials have confirmed that proponents of a 2018 medical use initiative failed to gather the necessary number of signatures to qualify for November’s ballot.

  • by NORML

    Legalize MarijuanaSixty-three percent of US voters believe that “marijuana should be made legal in the United States,” according to survey data released today by Quinnipiac University. The percentage is the highest support level ever reported in a nationwide Quinnipiac poll.

    The result is similar to those of other recent national polls, such as surveys by CBS News, Gallup, and Fox News.

    “Never in modern history has there existed greater public support for ending the nation’s nearly century-long failed experiment with marijuana criminalization,” said Justin Strekal, NORML’s Political Director. “As this momentum and public pressure continue to build, now is the time for elected officials to find their way to a political evolution. We are ready to welcome them to the cause of justice, fairness, and individual liberty.”

    He added, “In 2018, NORML members and marijuana reform supporters will be attending town halls, knocking on doors, and making political contributions with every intention of defeating candidates who maintain their reefer madness hysteria as a justification to treat cannabis consumers as second-class citizens.”

    The poll’s results also revealed overwhelming support for medical marijuana and sweeping opposition to federal intervention in states that have reformed their marijuana laws.

    From Quinnipiac:

    Ninety-three percent of voters support the medical use of marijuana, as authorized by a doctor. This widespread support is in line with the results of prior polls.

    Voters oppose the enforcement of federal laws against marijuana in states that have legalized medical or recreational marijuana by a margin of 70 percent to 23 percent. Seventy-four percent of respondents say they support federal legislation to prohibit the federal government from intervening in states that have enacted marijuana regulatory laws.

    Twenty-two percent of respondents acknowledged that they reside in a state where the recreational, adult use of marijuana is legal, and 61 percent of Americans reject the claim that cannabis is a supposed “gateway drug.”

    Read the full results here.

  • by Justin Strekal, NORML Political Director April 23, 2018

    NORML today hand-delivered over 10,000 written comments from US citizens calling on federal and international agencies to amend the international prohibition of cannabis. The public comments, which were requested earlier this month by the US Food and Drug Administration, will be considered as part of the World Health Organization’s ongoing review of the plant’s international classification.

    Under international treaties, the marijuana plant is classified in the most restrictive schedules available for controlled substances. NORML maintains that this scheduling does not accurately reflect the plant’s widespread therapeutic acceptance and relatively low abuse potential.

     

    The United National’s international prohibition of cannabis is a relic from a bygone era. This decision, which was largely a political one made over 50 years ago, does not accurately reflect either the available science or the rapidly changing political and cultural status of cannabis worldwide.

    Members of NORML’s Board of Directors also submitted their own written testimony to the FDA, opining: “In general, the safety, dependence, and usage profile of cannabis compares favorably to alcohol, tobacco, and other unscheduled substances. For this reason, NORML believes that cannabis [ultimately] should be withdrawn from the treaty framework entirely.”

    As of 1pm EST on April 23rd, there are only 6,566 comments submitted through the federal site. With the comments by NORML members, we will have submitted 61% of all public comments should that number hold.

    Background per Regulations.gov:

    The United States is a party to the 1971 Convention on Psychotropic Substances (Psychotropic Convention). Article 2 of the Psychotropic Convention provides that if a party to the convention or WHO has information about a substance, which in its opinion may require international control or change in such control, it shall so notify the Secretary-General of the United Nations (the U.N. Secretary-General) and provide the U.N. Secretary-General with information in support of its opinion.

    Paragraph (d)(2)(A) of the CSA (21 U.S.C. 811) (Title II of the Comprehensive Drug Abuse Prevention and Control Act of 1970) provides that when WHO notifies the United States under Article 2 of the Psychotropic Convention that it has information that may justify adding a drug or other substances to one of the schedules of the Psychotropic Convention, transferring a drug or substance from one schedule to another, or deleting it from the schedules, the Secretary of State must transmit the notice to the Secretary of Health and Human Services (Secretary of HHS). The Secretary of HHS must then publish the notice in the Federal Register and provide opportunity for interested persons to submit comments that will be considered by HHS in its preparation of the scientific and medical evaluations of the drug or substance.

Page 2 of 34912345...102030...Last »